Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
The underlying goal of this study is to assess [18F] CFPyPB PET imaging as a tool to evaluate
the activity of the GlyT1 receptors in the brain of Parkinson's Disease (PD) and Alzheimer
Disease (AD) research participants.